AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion

Clinical trial NCT04099966 · RECRUITING

Trial details

NCT number: NCT04099966
Sponsor: Mitchell Cairo
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Leukemia Severe Aplastic Anemia Non-hodgkin Lymphoma Hodgkin Lymphoma Kostmann Diamond Blackfan Anemia Amegakaryocytic Thrombocytopenia Sickle Cell Disease Beta-Thalassemia

Start date: 2021-04-01
Primary completion: 2026-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.